Education
About Us
Working with TipRanks
Follow Us
Hikal Limited (IN:HIKAL)
:HIKAL
HIKAL Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹309.45 - ₹464.50
Previous CloseN/A
Volume141.84K
Average Volume (3M)21.00K
Market Cap
₹42.28B
Enterprise Value₹49.74B
Total Cash (Recent Filing)₹180.00M
Total Debt (Recent Filing)₹7.65B
Price to Earnings (P/E)46.6
Beta1.14
Next Earnings
Aug 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Feb 07, 2025Dividend Yield0.35%
Share Statistics
EPS (TTM)4.10
Shares Outstanding123,300,750
10 Day Avg. Volume28,801
30 Day Avg. Volume21,004
Financial Highlights & Ratios
PEG Ratio2.15
Price to Book (P/B)3.35
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hikal Limited News
HIKAL FAQ
What was Hikal Limited’s price range in the past 12 months?
Hikal Limited lowest stock price was ₹309.45 and its highest was ₹464.50 in the past 12 months.
What is Hikal Limited’s market cap?
Hikal Limited’s market cap is ₹42.28B.
When is Hikal Limited’s upcoming earnings report date?
Hikal Limited’s upcoming earnings report date is Aug 12, 2025 which is in 26 days.
How were Hikal Limited’s earnings last quarter?
Hikal Limited released its earnings results on May 14, 2025. The company reported ₹4.1 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.1.
Is Hikal Limited overvalued?
According to Wall Street analysts Hikal Limited’s price is currently Overvalued.
Does Hikal Limited pay dividends?
Hikal Limited pays a Semiannually dividend of ₹0.6 which represents an annual dividend yield of 0.35%. See more information on Hikal Limited dividends here
What is Hikal Limited’s EPS estimate?
Hikal Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hikal Limited have?
Hikal Limited has 123,300,750 shares outstanding.
What happened to Hikal Limited’s price movement after its last earnings report?
Hikal Limited reported an EPS of ₹4.1 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.071%.
Which hedge fund is a major shareholder of Hikal Limited?
Currently, no hedge funds are holding shares in IN:HIKAL
Company Description
Hikal Limited
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Technical Analysis
Indoco Remedies Limited
―
Morepen Laboratories Limited
―
RPG Life Sciences Limited
―
Sequent Scientific Limited
―
Unichem Laboratories Limited
―